Furthermore, our results from a phenotype-genotype association study suggested that the single nucleotide polymorphism rs3020449 in the promoter region of ESR2 gene might affect progression of ovarian cancer [14]. This evidence concerns the gene ESR2 and ovarian carcinoma.